Type 1 Diabetes Epidemiology Analysis and Forecast to 2033
Powered by ![]()
All the vital news, analysis, and commentary curated by our industry experts.
Type 1 Diabetes Epidemiology Report Overview
In the 7MM, there were 3,012,498 diagnosed prevalent cases of Type 1 Diabetes Epidemiology in 2023. The market will register an AGR of less than 1% during 2023-2033. Type 1 diabetes (T1D), formally referred to as insulin-dependent diabetes or juvenile diabetes, is a chronic autoimmune disease that predominantly develops in childhood and young adulthood and accounts for approximately 5–10% of all diabetes cases. It is caused by the body’s immune system destroying pancreatic beta cells, which are responsible for producing a hormone that regulates blood sugar levels called insulin.
Type 1 Diabetes Epidemiology Market Outlook, 2023-2033 (Diagnosed Prevalent Cases)
Buy the Full Report for More Insights into the Type 1 Diabetes Epidemiology Market Forecast
The Type 1 Diabetes Epidemiology market research report provides an overview of the risk factors, comorbidities, and the global and historical trends of type 1 diabetes (T1D) in the seven major markets (7MM: US, France, Germany, Italy, Spain, UK, and Japan). The report includes a 10-year epidemiology forecast for T1D, segmented by age, sex, body mass index (BMI) (underweight/normal [BMI <25kg/m²], overweight [BMI 25–30kg/m²], and obese [BMI ≥30kg/m²]), hypoglycemic events (hypoglycemic and severe hypoglycemic events), brittle diabetes, diabetic ketoacidosis (DKA) events, and having at least one gene encoding for HLA-DQ8 for men and women of all ages.
| Market Size (2022) | 3,012,498 Cases |
| AGR (2023-2033) | <1% |
| Forecast Period | 2023-2033 |
| Key Countries | · The US
· France · Germany · Spain · Italy · The UK · Japan |
| Key Sex Segments | · Men
· Women |
| Enquire & Decide | Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase. |
Type 1 Diabetes Epidemiology Market Segmentation by Country
The key countries across the 7MM are the US, France, Germany, Spain, Italy, the UK, and Japan. In 2023, the US accounted for the highest percentage of diagnosed prevalent cases of Type 1 Diabetes Epidemiology in the 7MM. Furthermore, the country will experience the highest annual growth rate by 2033 with an increasing number of diagnosed prevalent cases.
`Type 1 Diabetes Epidemiology Market Analysis by Country, 2023 (%)
Buy the Full Report for More Country Insights into the Type 1 Diabetes Epidemiology Market
Download a Free Report Sample
Type 1 Diabetes Epidemiology Market Segmentation by Sex
Based on sex, the market can be segmented into men and women. In 2023, the diagnosed prevalent cases of Type 1 Diabetes Epidemiology in the 7MM were higher in men than women. Conversely, in Japan, the number of diagnosed prevalent cases of T1D were higher in women than men in the same year. Furthermore, Germany had the smallest variation in the number of diagnosed prevalent cases between men and women.
Type 1 Diabetes Epidemiology Market Analysis by Sex, 2023 (%)
Buy the Full Report for More Sex Insights into the Type 1 Diabetes Epidemiology Market
Segments Covered in the Report
Type 1 Diabetes Epidemiology Market Country Outlook (Diagnosed Prevalent Cases)
- The US
- France
- Germany
- Spain
- Italy
- The UK
- Japan
Type 1 Diabetes Epidemiology Market Sex Outlook (Diagnosed Prevalent Cases)
- Men
- Women
Scope
- The Type 1 Diabetes Epidemiology Report and Model provide an overview of the risk factors, comorbidities, and the global and historical trends of type 1 diabetes (T1D) in the seven major markets (7MM: US, France, Germany, Italy, Spain, UK, and Japan).
- The report includes a 10-year epidemiology forecast for T1D, segmented by age, sex, body mass index (BMI) (underweight/normal [BMI <25kg/m²], overweight [BMI 25–30kg/m²], and obese [BMI ≥30kg/m²]), hypoglycemic events (hypoglycemic and severe hypoglycemic events), brittle diabetes, diabetic ketoacidosis (DKA) events, and having at least one gene encoding for HLA-DQ8 for men and women of all ages.
- Additionally, the report also provides a 10-year epidemiological forecast for the diagnosed prevalent cases of T1D eligible for pancreas transplantation, with chronic kidney disease (CKD), and with cardiovascular disease (CVD) for men and women over 20 years old. The report also includes total prevalent cases of T1D for men and women of all ages.
Reasons to Buy
The T1D Epidemiology series will allow you to:
- Develop business strategies by understanding the trends shaping and driving the global T1D markets.
- Quantify patient populations in the global T1D markets to improve product design, pricing, and launch plans.
- Organize sales and marketing efforts by identifying the age groups, sex, BMI groups, disease conditions, and genetic groups that present the best opportunities for T1D therapeutics in each of the markets covered.
- Understand magnitude of the T1D population by age, sex, BMI groups, associated disease conditions, pancreas transplant eligibility, and genetic groups.
Table of Contents
Table
Figures
Frequently asked questions
-
How many diagnosed prevalent cases of Type 1 Diabetes Epidemiology were seen in the 7MM in 2023?
In 2023, there were 3,012,498 diagnosed prevalent cases of Type 1 Diabetes Epidemiology in the 7MM.
-
What will the growth rate of the Type 1 Diabetes Epidemiology market be during the forecast period?
The diagnosed prevalent cases of Type 1 Diabetes Epidemiology will register an AGR of less than 1% during 2023-2033.
-
Which was the leading sex segment in the Type 1 Diabetes Epidemiology market in 2023?
In 2023, the number of diagnosed prevalent cases of Type 1 Diabetes Epidemiology was higher in men in the 7MM combined.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Related reports
View more Type 1 Diabetes (Juvenile Diabetes) reports


